Mangalam Organics Limited has informed the Exchange regarding Board meeting held on May 10, 2025.
MANORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Organics' board approved audited standalone and consolidated financial results for Q4 and FY25 on May 10, 2025. Standalone full-year revenue from operations was Rs. 409.85 crore (vs Rs. 405.43 crore in FY24), with profit before tax jumping sharply to Rs. 10.68 crore from Rs. 3.47 crore. Consolidated revenue rose to Rs. 530.01 crore from Rs. 493.52 crore, and consolidated PBT surged to Rs. 16.62 crore from Rs. 3.99 crore. Standalone EPS for FY25 stood at Rs. 8.87 (vs Rs. 4.76), and consolidated EPS at Rs. 14.60 (vs Rs. 4.92). However, operating cash flow turned negative at the standalone level (Rs. -46.49 crore vs Rs. +54.72 crore last year) due to a sharp build-up in inventories and receivables. Auditor NGST & Associates issued an unmodified opinion on both sets of results.
Strong profit growth and margin expansion are positives for shareholders, driven by lower raw material costs and better operating leverage. However, the steep swing to negative operating cash flow and rising short-term borrowings (standalone current borrowings up to Rs. 227.45 crore from Rs. 147.75 crore) suggest working capital stress that investors should monitor closely.